Home / Providers / NexLife / Semaglutide — standard inj
This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
Researched by Dr. Parmis·Medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP·Released ·Last reviewed

NexLife semaglutide (standard injection): price by plan, November 2026

What NexLife charges for its standard compounded semaglutide injection at each plan length, what the price covers, and how it compares.

Direct answer

As of November 6, 2026, NexLife's standard compounded semaglutide injection costs $109 a month month to month, or $105, $99 and $95 a month on 3-, 6- and 12-month plans. A 12-month plan totals $1,140. The price is the same at every dose and there is no membership fee. These replace the $139, $132, $125 and $119 rates in force on October 15, 2026. Compounded semaglutide is not FDA-approved.

See NexLife's current plans →

What does each plan length cost?

NexLife semaglutide, standard injection, as of November 6, 2026. Same price at every dose; no membership
PlanPer monthTotal for the termSaving vs month to month, per term
Month to month$109$109—
3-month$105$315$12
6-month$99$594$60
12-month$95$1,140$168
How multi-month plans are billed: what the plan pages sayNexLife's plan pages say: "Plans continue monthly unless canceled"; "Savings applied at checkout on eligible multi-month plans"; and "3-, 6-, and 12-month plans start only if you're prescribed; unshipped months are refunded if treatment stops." They do not say in one sentence whether a multi-month plan is charged each month or collected up front. Ask at checkout and keep the answer in writing.

The saving for committing is modest: $4 a month on a 3-month plan, $10 on a 6-month plan, $14 on a 12-month plan. If you are new to semaglutide, the month-to-month plan costs $168 more over a year than the 12-month plan, and leaves you free to stop.

What does the price include?

Labs are not stated as included on any NexLife page we read. If you need baseline labs, ask who orders them and who pays.

What are the cancellation and refund terms?

See NexLife's current plans →

How has this price changed?

NexLife semaglutide, standard injection: price history, monthly price on month-to-month / 3- / 6- / 12-month plans
DatePricesSource
Sept 4, 2026$139 / $132 / $125 / $119This site's capture
Oct 15, 2026$139 / $132 / $125 / $119First-party read
Nov 6, 2026$109 / $105 / $99 / $95Plan pages, current

How does it compare with other semaglutide programs?

Among the 22 compounded semaglutide programs in our index, lowest all-in figures run from $49 to $169 a month, median $94. NexLife's $95 on a 12-month plan is 12th. On standing month-to-month rates with no membership and no sale, Mondae ($87) and Eden Health ($99) charge less than NexLife's $109 (read Oct 15, 2026). Lower stickers from Collective, WellMedr, SnagRx, Embody and NextMeds need a membership, a sale, a prepaid year or an unstated plan term. Full rows: pricing database.

NexLife's own tirzepatide plan is $129 month to month and $115 a month on 12 months, $20 a month more than semaglutide on either plan. Its microdose semaglutide plan lists the same prices as this one, and its semaglutide ODT costs $70 a month more on a 12-month plan.

See NexLife's current plans →

What does the evidence cover, and what does it not?

The trial evidence behind semaglutide comes from Novo Nordisk's approved injection. In STEP 1 (Wilding et al., NEJM 2021), semaglutide 2.4 mg weekly produced a mean 14.9% weight loss at 68 weeks against 2.4% on placebo. SELECT found a 20% relative reduction in major cardiovascular events with the same approved drug. In SURMOUNT-5 (Aronne et al., NEJM 2025), tirzepatide produced 20.2% against 13.7% for semaglutide at 72 weeks, in an open-label trial funded by Lilly.

No trial has tested a compounded semaglutide product. Trial means are averages for a population; they do not tell you what you will lose.

Compounded is not the approved productCompounded semaglutide is not FDA-approved. It is made with the drug in Wegovy and Ozempic, not the same product, and FDA does not review a compounder's formulation, strength or sterility before it reaches you. FDA proposed on April 30, 2026 not to place semaglutide on the 503B bulks list; we found no final decision as of October 15, 2026.

Who does what when you order online?

The entities behind an online prescription
EntityWhat it isRegulated by
Telehealth company (NexLife)Arranges the visit, billing and shipping. Not a pharmacy.State rules; FTC for advertising
Prescribing clinician (NexLife Medical Group)Licensed clinician who evaluates you and writes the prescription.State medical or nursing board
503A compounding pharmacyState-licensed pharmacy compounding for an individual prescription. NexLife's plan pages name three.State board of pharmacy; FDA for some provisions
503B outsourcing facilityFDA-registered facility that may compound in bulk. None named by NexLife.FDA, including CGMP inspection
Manufacturer (Novo Nordisk)Makes FDA-approved Wegovy and Ozempic.FDA premarket approval

There is no such thing as an "FDA-approved pharmacy". A pharmacy is state-licensed or FDA-registered; neither makes a compounded drug FDA-approved. Pharmacy details: NexLife pharmacy.

Which costs should you check before you enroll?

See NexLife's current plans →

Sources

  1. NexLife, semaglutide plans, read November 6, 2026.
  2. Semaglutide Watchdog, data/prices.json, data/facts.json and data/price-history-2026.json, November 9, 2026 (CC BY 4.0).
  3. Seller pricing pages for the comparison programs, read October 15, 2026.
  4. Wilding JPH et al., Once-weekly semaglutide in adults with overweight or obesity (STEP 1), N Engl J Med 2021.
  5. Aronne LJ et al., SURMOUNT-5, N Engl J Med 2025.
  6. FDA, 503B bulks list proposal, April 30, 2026 (91 FR 23431).
  7. FDA, Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, current as of October 1, 2026.

Frequently asked questions

How much is NexLife semaglutide per month?

As of November 6, 2026, NexLife charges $109 a month for its standard compounded semaglutide injection month to month, $105 on a 3-month plan, $99 on a 6-month plan and $95 on a 12-month plan. The 12-month plan totals $1,140. The price is the same at every dose, and the plan pages list no membership fee.

Does the price go up when my dose goes up?

No. NexLife's plan pages state the same price at every dose, so the price you are quoted at the starting dose is the price at the maintenance dose. That is worth checking with any program you compare, because some sellers, such as GobyMeds on our October 15, 2026 read, charge more as the dose rises.

Is the 12-month plan paid up front?

The plan pages do not say in one sentence. They say plans "continue monthly unless canceled", that savings apply at checkout on eligible multi-month plans, and that unshipped months are refunded if treatment stops. Ask NexLife at checkout how much is charged on day one for the plan you choose, and keep the answer in writing.

Is NexLife semaglutide the same as Wegovy?

No. It is compounded semaglutide, made with the drug in Wegovy and Ozempic but not the same product, and it is not FDA-approved. It is filled by a state-licensed 503A pharmacy; NexLife's plan pages name three. Wegovy's trial results, such as the 14.9% mean loss in STEP 1, come from the approved injection.

Who charges less than NexLife for semaglutide?

On standing month-to-month rates with no membership and no sale, Mondae at $87 and Eden Health at $99 charge less than NexLife's $109, read October 15, 2026. Collective is $59 plus a $199 yearly membership, about $76 all-in. WellMedr, SnagRx, Embody and NextMeds print lower headline figures that depend on a sale, a prepaid year or an unstated plan term.

Researched ByDr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed ByDr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.